Chemokines such as CC chemokine ligand 2 (CCL2), CCL5, and vascular endothelial growth factor can recruit TAMs to the tumor-site, thus contributing to the maintenance of an immunosuppressive TME [65]. Here, CCL5 is linked to neoplasm.